These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Loumaye E, Martineau I, Piazzi A, O'Dea L, Ince S, Howles C, Decosterd G, Van Loon K, Galazka A. Hum Reprod; 1996 Sep; 11 Suppl 1():95-107; discussion 117-9. PubMed ID: 8968783 [No Abstract] [Full Text] [Related]
8. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895 [Abstract] [Full Text] [Related]
9. Recombinant reproduction. De Koning WJ, Walsh GA, Wrynn AS, Headon DR. Biotechnology (N Y); 1994 Oct; 12(10):988-92. PubMed ID: 7765410 [No Abstract] [Full Text] [Related]